Comparative Pharmacology
Head-to-head clinical analysis: NUPRIN versus OXYPHENBUTAZONE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NUPRIN versus OXYPHENBUTAZONE.
NUPRIN vs OXYPHENBUTAZONE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (Cox-1 and Cox-2) activity, reducing prostaglandin synthesis. This results in anti-inflammatory, analgesic, and antipyretic effects.
Oxyphenbutazone is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing prostaglandin synthesis, which mediates inflammation, pain, and fever.
200-400 mg orally every 4-6 hours as needed; maximum 1200 mg/day (OTC) or 3200 mg/day (prescription).
100-200 mg orally 3-4 times daily, not to exceed 600 mg/day.
None Documented
None Documented
Approximately 2 hours (range 1.5-3 hours) for the terminal elimination half-life in adults. Longer half-life in elderly and patients with renal impairment.
Clinical Note
moderateOxyphenbutazone + Gatifloxacin
"Oxyphenbutazone may increase the neuroexcitatory activities of Gatifloxacin."
Clinical Note
moderateOxyphenbutazone + Rosoxacin
"Oxyphenbutazone may increase the neuroexcitatory activities of Rosoxacin."
Clinical Note
moderateOxyphenbutazone + Levofloxacin
"Oxyphenbutazone may increase the neuroexcitatory activities of Levofloxacin."
Clinical Note
moderateOxyphenbutazone + Trovafloxacin
Terminal elimination half-life ranges from 27 to 64 hours (mean ~50 hours). Prolonged in hepatic or renal impairment; may extend up to 100 hours in elderly.
Renal elimination of conjugates and metabolites (90%) and biliary/fecal (10%). Unchanged drug excretion is negligible (<1%).
Primarily renal (biliary/fecal minor). Approximately 60-70% excreted in urine as glucuronide conjugates and unchanged drug; 5-10% in feces via bile.
Category C
Category C
Nonsteroidal Anti-inflammatory Drug
Nonsteroidal Anti-inflammatory Drug
"Oxyphenbutazone may increase the neuroexcitatory activities of Trovafloxacin."